MANAGEMENT OF PCOD WITH HOMOEOPATHIC MEDICINES AND LIFE STYLE MODIFICATION

ASSESSMENT OF THE TYPE OF POLYCYSTIC OVARIAN SYNDROME AND ITS MANAGEMENT WITH REFERANCE TO APHORISMS 77 AND 261 A RANDOMISED PLACEBO CONTROLLED CROSS OVER STUDY - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/09/073189

Enrollment

Registered

2024-09-02

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N926- Irregular menstruation, unspecified

Interventions

Intervention1: Randomised placebo controlled cross over study: group A will be treated according to the principles of homoeopathy and group B will be given placebo with advice to do life style modific

Eligibility

Inclusion criteria

Inclusion criteria: 44 diagnosed cases of PCOS confirmed on t he basis of Rotterdam criteria with irregular menstrual cycle

Exclusion criteria

Exclusion criteria: Pregnant females Cases associated with serious illness Metabolic syndrome

Design outcomes

Primary

Measure	Time frame
title 1.Global Acne Severity Scale 2.Ferriman Gallway Scale of Hirsuitism 3.USG findings Description 1.GLOBAL ACNE SEVERITY SCALE FINAL SCORE- INITIAL SCORE. 2. FERRIMAN-GALLWAY SCALE FINAL SCORE-INITIAL SCORE. 3. FINAL USG SCORE –INITIAL USG SCORE. Timepoint: 4 months	—

Secondary

Measure	Time frame
comparison of the results of Rotterdam criteria in both groups in order to check the need of medication in case of PCOSTimepoint: After 1 year	—

Countries

India

Contacts

Public ContactSHAFNA T P

GOVT HOMOEOPATHIC MEDICAL COLLEGE- KOZHIKODE

ritheshb.dr@gmail.com9400111908

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026